Related Blog Posts
Nothing to see... move along.
Related News
KAR Auction skids on its IPO
4 hours ago ago from BloggingStocks
As the IPO market winds down for the year, activity has mostly been lackluster. Just take today's offering from KAR Auction Services. With an initial price range of $15-$17, KAR was only able to get its deal done at $12. In all, the company sold 25 million shares. The lead underwriters on the deal included Goldman Sachs ( GS ) and Credit Suisse ( CS ). Then again, KAR is in a challenging business; that is, auctions for used and damaged ...
Related contentOYO Geospace Reports Fiscal Year 2009 Results
10 hours ago ago from PopEater
OYO Geospace (NASDAQ:OYOG) today announced net income of $1.8 million, or $0.29 per diluted share, on revenues of $92.9 million for its fiscal year ended September 30, 2009. This compares with a net income of $14.2 million, or $2.31 per diluted share, on revenues of $134.5 million for the prior fiscal year. For the fourth quarter ended September 30, 2009, the company recorded sales of $22.7 million and a net loss of $1.8 million, or $0.30 per ...
Related contentQiao Xing Universal Telephone, Inc. Reports Unaudited First Half 2009 Financial Results
11 hours ago ago from PopEater
HUIZHOU, China , Dec. 11 /PRNewswire-Asia-FirstCall/ -- Qiao Xing Universal Telephone, Inc. (Nasdaq: XING) ("the Company" or "XING"), an emerging Chinese resources company headquartered in Huizhou , Guangdong Province , today released its unaudited financial results for the six months ended June 30, 2009 . "Fiscal 2009 has been a year of transition for us, as we moved to aggressively re-deploy our capital and focus our efforts and management ...
Related contentChina Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009
13 hours ago ago from PopEater
HONG KONG , Dec. 11 /PRNewswire-Asia-FirstCall/ -- China Cord Blood Corporation ("CCBC" or "the Company") (NYSE: CO), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced its unaudited financial results for the quarter and six months ended September 30, 2009 . Highlights as of September 30, 2009 -- For the quarter ended September 30, 2009, ...
Related contentBoston Scientific prices $2B in senior notes
12 hours ago ago from PopEater
NEW YORK -Medical device maker Boston Scientific Corp. said Friday it priced a public offering of $2 billion in senior notes and will record a charge in the fourth quarter. The offering consists of $850 million of 4.5 percent notes due Jan. 2015; $850 million of 6 percent notes due Jan. 2020; and $300 million of 7.37 percent notes due Jan. 2040. The company expects that the offering will close on Monday. Proceeds will be used for general ...
Related content
